| Date Filed | Type | Description |
| 07/12/2023 |
4
| Duker Jay S. (President and CEO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 restricted stock units
@ $0
Granted 100,000 options to buy
@ $9.11, valued at
$911k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Duker Jay S. (President and COO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 124,755 options to buy
@ $3.26, valued at
$406.7k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2022 |
4
| Duker Jay S. (COO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 65,300 options to buy
@ $9.45, valued at
$617.1k
|
|
| 09/09/2022 |
4/A
| Duker Jay S. (COO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 239,700 options to buy
@ $11.47, valued at
$2.7M
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Duker Jay S. (COO) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 15,258 restricted stock units
@ $0
Granted 305,000 options to buy
@ $11.47, valued at
$3.5M
|
|
| 11/03/2021 |
3
| Duker Jay S. (COO) has filed a Form 3 on EyePoint Pharmaceuticals, Inc. |
| 05/05/2021 |
4
| Duker Jay S. (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 92,500 options
@ $2.79, valued at
$258.1k
|
|
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Duker Jay S. (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 52,500 options
@ $1.48, valued at
$77.7k
|
|
| 04/16/2019 |
4
| Duker Jay S. (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $1.77, valued at
$35.4k
|
|
| 04/03/2019 |
4
| Duker Jay S. (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $1.89, valued at
$9.5k
|
|
| 06/29/2018 |
4
| Duker Jay S. (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 12,500 restricted stock units
@ $0 |
|
| 06/26/2018 |
4
| Duker Jay S. (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 26,667 options to buy
@ $1.95, valued at
$52k
Granted 6,667 restricted stock units
@ $0 |
|
| 06/14/2018 |
4
| Duker Jay S. (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 52,500 options
@ $2.24, valued at
$117.6k
|
|
| 12/19/2017 |
4
| Duker Jay S. (Director) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 20,000 options to buy
@ $1.77, valued at
$35.4k
Granted 12,500 restricted stock units
@ $0 |
|
| 05/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/27/2016 |
3
| Duker Jay S. (Director) has filed a Form 3 on pSivida Corp. |
| 06/10/2016 |
4
| Duker Jay S. (Director) has filed a Form 4 on Eleven Biotherapeutics, Inc.|
Txns:
| Granted 8,072 options
@ $1.83, valued at
$14.8k
|
|